A pathogenic relationship between a regulator of the actin cytoskeleton and serum response factor

Genetics

Volumn 186, Issue 1, 2010, Pages 147-157

  Verdoni, Angela M ^a   Schuster, Keaton J ^a   Cole, Brian S ^a   Ikeda, Akihiro ^a   Kao, Winston W ^b   Ikeda, Sakae ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN DEPOLYMERIZING FACTOR; SERUM RESPONSE FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; CYTOSKELETON; EPITHELIUM CELL; GENE EXPRESSION; INFLAMMATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ACTINS; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOSKELETON; DESTRIN; DOXYCYCLINE; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; GENE EXPRESSION REGULATION; INFLAMMATION; MICE; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; SERUM RESPONSE FACTOR;

MUS;

EID: 78751664654     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.110.117309     Document Type: Article

References (50)

1. ALLAVENA, P., C. GARLANDA, M. G. BORRELLO, A. SICA and A. MANTOVANI, 2008 Pathways connecting inflammation and cancer. Curr. Opin. Genet. Dev. 18: 3-10.
2. AMBATI, B. K., M. NOZAKI, N. SINGH, A. TAKEDA, P. D. JANI et al., 2006 Corneal avascularity is due to soluble VEGF receptor-1. Nature 443: 993-997.
3. BAI, S., M. W. NASSER, B. WANG, S. H. HSU, J. DATTA et al., 2009 MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to Sorafenib. J. Biol. Chem. 284(46):32015-32027.
4. BAMBURG, J. R., and O. P. WIGGAN, 2002 ADF/cofilin and actin dynamics in disease. Trends Cell. Biol. 12: 598-605.
5. BARKAN, D., H. KLEINMAN, J. L. SIMMONS, H. ASMUSSEN, A. K. KAMARAJU et al., 2008 Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 68: 6241-6250.
6. BOCK, F., J. ONDERKA, D. HOS, F. HORN, P. MARTUS et al., 2008 Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp. Eye Res. 87: 462-470.
7. CHAI, J., D. BAATAR and A. TARNAWSKI, 2004a Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology 126: 1809-1818.
8. CHAI, J., M. K. JONES and A. S. TARNAWSKI, 2004b Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis. FASEB J. 18: 1264-1266.
9. CHIKAMA, T., Y. HAYASHI, C. Y. LIU, N. TERAI, K. TERAI et al., 2005 Characterization of tetracycline-inducible bitransgenic Krt12rtTA/+/tet-O-LacZ mice. Invest. Ophthalmol. Vis. Sci. 46: 1966-1972.
10. CHOI, H. N., K. R. KIM, J. H. LEE, H. S. PARK, K. Y. JANG et al., 2009 Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex. Oncol. Rep. 21: 57-63.
11. CURSIEFEN, C., 2007 Immune privilege and angiogenic privilege of the cornea. Chem. Immunol. Allergy 92: 50-57.
12. CURSIEFEN, C., S. IKEDA, P. M. NISHINA, R. S. SMITH, A. IKEDA et al., 2005 Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am. J. Pathol. 166: 1367-1377.
13. D'AURA SWANSON, C., R. T. PANIAGUA, T. M. LINDSTROM and W. H. ROBINSON, 2009 Tyrosine kinases as targets for the treatment of rheumatoid arthritis. Nat. Rev. Rheumatol. 5: 317-324.
14. EISENMANN, K. M., K. J. DYKEMA, S. F. MATHESON, N. F. KENT, A. D. DEWARD et al., 2009 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. Oncogene 28: 3429-3441.
15. FIFE, R. S., G. W. SLEDGE, JR., S. SISSONS and B. ZERLER, 2000 Effects of tetracyclines on angiogenesis in vitro. Cancer Lett. 153: 75-78.
16. FRANCO, C. A., and Z. LI, 2009 SRF in angiogenesis: branching the vascular system. Cell Adh. Migr. 3: 264-267.
17. FRANCO, C. A., M. MERICSKAY, A. PARLAKIAN, G. GARY-BOBO, J. GAO LI et al., 2008 Serum response factor is required for sprouting angiogenesis and vascular integrity. Dev. Cell 15: 448-461.
18. GAUTHIER-ROUVIERE, C., J. C. CAVADORE, J. M. BLANCHARD, N. J. LAMB and A. FERNANDEZ, 1991 p67SRF is a constitutive nuclear protein implicated in the modulation of genes required throughout the G1 period. Cell Regul. 2: 575-588.
19. GENIN, O., G. RECHAVI, A. NAGLER, O. BEN-ITZHAK, K. J. NAZEMI et al., 2008 Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: A novel target for treatment? Neoplasia 10: 940-948.
20. GRAY, D. S., W. F. LIU, C. J. SHEN, K. BHADRIRAJU, C. M. NELSON et al., 2008 Engineering amount of cell-cell contact demonstrates biphasic proliferative regulation through RhoA and the actin cytoskeleton. Exp. Cell Res. 314: 2846-2854.
21. GUAN, M., V. TRIPATHI, X. ZHOU and N. C. POPESCU, 2008 Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy. Cancer Gene Ther. 15: 371-381.
22. HU, M., J. L. YANG, H. TENG, Y. Q. JIA, R. WANG et al., 2008 Anti-angiogenesis therapy based on the bone marrow-derived stromalcells genetically engineered to express sFlt-1 in mouse tumor model. BMC Cancer 8: 306.
23. IKEDA, S., L. A. CUNNINGHAM, D. BOGGESS, N.HAWES, C. D. HOBSON et al., 2003 Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor). Hum. Mol. Genet. 12: 1029-1037.
24. KOEGEL, H., L. VON TOBEL, M. SCHAFER, S. ALBERTI, E. KREMMER et al., 2009 Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J. Clin. Invest. 119: 899-910.
25. LEHRER, M. S., T. T. SUN and R. M. LAVKER, 1998 Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation. J. Cell Sci. 111(Pt 19): 2867-2875.
26. LEWIS, J. D., J. J. DEREN and G. R. LICHTENSTEIN, 1999 Cancer risk in patients with inflammatory bowel disease. Gastroenterol. Clin. North Am. 28: 459-477.
27. LIU, C. Y., G. ZHU, A. WESTERHAUSEN-LARSON, R. CONVERSE, C. W. KAO et al., 1993 Cornea-specific expression of K12 keratin during mouse development. Curr. Eye Res. 12: 963-974.
28. LIU, J., J. LI, C. SU, B. HUANG and S. LUO, 2007 Soluble Fms-like tyrosine kinase-1 expression inhibits the growth of multiple myeloma in nude mice. Acta Biochim. Biophys. Sin. (Shanghai) 39: 499-506.
29. LYULCHEVA, E., E. TAYLOR, M. MICHAEL, A. VEHLOW, S. TAN et al., 2008 Drosophila pico and its mammalian ortholog lamellipodin activate serum response factor and promote cell proliferation. Dev. Cell 15: 680-690.
30. MEDJKANE, S., C. PEREZ-SANCHEZ, C. GAGGIOLI, E. SAHAI and R. TREISMAN, 2009 Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat. Cell Biol. 11: 257-268.
31. MIANO, J. M., N. RAMANAN, M. A. GEORGER, K. L. DE MESY BENTLEY, R. L. EMERSON et al., 2004 Restricted inactivation of serum response factor to the cardiovascular system. Proc. Natl. Acad. Sci. USA 101: 17132-17137.
32. MIANO, J. M., X. LONG and K. FUJIWARA, 2007 Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 292: C70-C81.
33. MIRALLES, F., G. POSERN, A. I. ZAROMYTIDOU and R. TREISMAN, 2003 Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113: 329-342.
34. NOTARA, M., A. ALATZA, J. GILFILLAN, A. R. HARRIS, H. J. LEVIS et al., 2010 In sickness and in health: corneal epithelial stem cell biology, pathology and therapy. Exp. Eye Res. 90: 188-195.
35. PARK, M. Y., K. R. KIM, H. S. PARK, B. H. PARK, H. N. CHOI et al., 2007 Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition. Int. J. Oncol. 31: 1309-1315.
36. PELLEGRIN S., and H. MELLOR, 2007 Actin stress fibres. J. Cell Sci. 120: 3491-3499.
37. PERL, A. K., S. E. WERT, A. NAGY, C. G. LOBE and J. A. WHITSETT, 2002 Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc. Natl. Acad. Sci. USA 99: 10482-10487.
38. RAMACHANDRA, S., S. S. D'SOUZA, A. E.GURURAJ, M. S. SHAILA and B. P. SALIMATH, 2009 Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo. J. Gene Med. 11: 422-434.
39. REN, K., H. JIN, C. BIAN, H. HE, X. LIU et al., 2008 MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway. J. Biol. Chem. 283: 35598-35605.
40. SMITH, R. S., N. L. HAWES, S. D. KUHLMANN, J. R. HECKENLIVELY, B. CHANG et al., 1996 Corn1: a mouse model for corneal surface disease and neovascularization. Invest. Ophthalmol. Vis. Sci. 37: 397-404.
41. VARTIAINEN, M. K., S. GUETTLER, B. LARIJANI and R. TREISMAN, 2007 Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316: 1749-1752.
42. VERDONI, A. M., N. AOYAMA, A. IKEDA and S. IKEDA, 2008a Effect of destrin mutations on the gene expression profile in vivo. Physiol. Genomics 34: 9-21.
43. VERDONI, A. M., R. S. SMITH, A. IKEDA and S. IKEDA, 2008b Defects in actin dynamics lead to an autoinflammatory condition through the upregulation of CXCL5. PLoS One 3: e2701.
44. VERDONI, A. M., S. IKEDA and A. IKEDA, 2010 Serum response factor is essential for the proper development of skin epithelium. Mamm. Genome 21: 64-76.
45. WU, R. L., G. ZHU, S. GALVIN, C. XU, T. HASEBA et al., 1994 Lineage-specific and differentiation-dependent expression of K12 keratin in rabbit corneal/limbal epithelial cells: cDNA cloning and northern blot analysis. Differentiation 55: 137-144.
46. YAMAGUCHI, S., K. ASANOMA, T. TAKAO, K. KATO and N. WAKE, 2009 Homeobox geneHOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor. Int. J. Cancer 124: 2577-2588.
47. YEOH, S., B. POPE, H.G. MANNHERZ, and A. WEEDS, 2002 Determining the differences in actin binding by human ADF and cofilin. J. Mol. Biol. 315: 911-925.
48. ZEMLJIC-HARPF A., A. M.MANSO, R.S. ROSS, 2009 Vinculin and talin: focus on the myocardium. J. Investig. Med. 57: 849-855.
49. ZHANG, W., J. ZHAO, L. CHEN, M. M. URBANOWICZ and T. NAGASAKI, 2008 Abnormal epithelial homeostasis in the cornea of mice with a destrin deletion. Mol. Vis. 14: 1929-1939.
50. ZHANG, Z., W. ZOU, J. WANG, J. GU, Y. DANG et al., 2005 Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1. Mol. Ther. 11: 553-562.